FDA recall record

pure encapsulations AI Enzymes DIETARY SUPPLEMENT 120 CAPSULES recall — FDA F-0397-2018

Product contains undeclared sulfites.

Class IIIclassification
F-0397-2018official record ID
Dec 6, 2017report date

Recall record at a glance

Official recordF-0397-2018
CategoryFood Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmPure Encapsulations, Inc.
Report dateDec 6, 2017
Recall initiation dateNov 17, 2017
QuantityN/A
LocationSudbury, MA, United States

Official product description

pure encapsulations AI Enzymes DIETARY SUPPLEMENT 120 CAPSULES UPC: 7 66298 00318 4 and 60 CAPSULES UPC: 7 66298 00317 7

Why the product was recalled

Product contains undeclared sulfites.

Distribution information

NH, AZ, CO, OH, NC

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.